Document is current
Any future updates will be listed below
-
Authors
Faguer, Stanislas https://orcid.org/0000-0003-0553-0927
Delabesse, Eric
Paul, Carle
Pasquet, Marlène
- License Information
-
More Information
Article History
Received: 23 November 2023
Accepted: 11 December 2023
First Online: 22 December 2023
Declarations
:
: Not applicable.
: This study was conducted according to the Declaration of Helsinki (2004). The patient’s oral consent to be included in the Nephrogene cohort (biological collection approved by the French National Ethics Committee; N° DC-2011–138) and that her case was reported.
: SF received fees for scientific advisory boards, lectures, and consultating from Abionyx Pharma, Genzyme-Sanofi, CSL-Vifor, GlaxoSmithKline, AstraZeneca-Alexion, and Baxter. CP has received grants and has been consultant for Almirall, Amgen, Abbvie, Apogee therapeutics, BMS, Boehringer, Celgene, Galderma, GlaxoSmithKline, Eli Lilly, Iqvia, Janssen, Leo Pharma, Merck, Mylan, Novartis, Pfizer, Pierre Fabre, Sanofi, and UCB pharma. ED and MP declared no conflict of interest.
